• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. ULTRASONIC PROBE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. ULTRASONIC PROBE Back to Search Results
Model Number UM-S20-17S
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Pneumothorax (2012)
Event Date 09/16/2022
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled "clinical utility of rapid on-site evaluation of touch imprint cytology during cryobiopsy for peripheral pulmonary lesions." with increasing interest in precision medicine for lung cancer, cryobiopsy is expected to improve the success rate not only for histological diagnosis, but also for next-generation sequencing.Rapid on-site evaluation (rose) is an immediate cytological evaluation performed during bronchoscopy.However, little is known about its clinical utility during cryobiopsy.We retrospectively reviewed the data of 63 consecutive patients who underwent cryobiopsy with rose of touch imprint cytology (rose-tic) for solid peripheral pulmonary lesions.When the results of rose-tic of each patient were compared directly with the histological findings of the corresponding specimen, the sensitivity, specificity, and positive and negative predictive values were 69.8%, 90.0%, 93.8%, and 58.1%, respectively.The concordance rate was 76.2%.Therefore, we believe that rose-tic, due to its high specificity and positive predictive value, may be a potential tool in deciding whether cryobiopsy sampling could be finished during bronchoscopy.Mild bleeding 23 patients defined as "blood suctioning required for <1 min." moderate bleeding 35 patients defined as "suctioning required for >1 min; repeat wedging of the bronchoscope for persistent bleeding needed; application of cold saline, diluted vasoactive substance, or thrombin." severe bleeding 1 patient defined as "selective intubation needed for <20 min." postinterventional pneumothorax 1 patient.This literature article requires 3 reports.The related patient identifiers are as follows: (b)(6): bf-p260f.(b)(6): bf-p290.(b)(6): um-s20-17s.This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Manufacturer Narrative
This supplemental report is being submitted to provided additional information from the author and to provide additional information based on the legal manufacturer's final investigation.New information added to the following fields: b5 and h6.The device history record was unable to be reviewed for this device since no product malfunction was reported.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, it is likely the reported event is an accident or a complication associated with a surgical procedure using the subject device.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Olympus will continue to monitor field performance for this device.
 
Event Description
Additional information received from the author: in the medical opinion of the author, the olympus device did not cause malfunction nor the adverse events reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRASONIC PROBE
Type of Device
ULTRASONIC PROBE
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer Contact
masaharu hirose
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8-061
JA   961-8061
426422891
MDR Report Key15625323
MDR Text Key301926314
Report Number3002808148-2022-03276
Device Sequence Number1
Product Code ITX
UDI-Device Identifier04953170368479
UDI-Public04953170368479
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K982323
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUM-S20-17S
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/21/2022
Initial Date FDA Received10/18/2022
Supplement Dates Manufacturer Received10/28/2022
Supplement Dates FDA Received11/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-